Laddar...

Targeting PD-1/PD-L1 interactions for cancer immunotherapy

Tumors have developed multiple immunosuppressive mechanisms to turn down the innate and the effector arms of the immune system, thus compromising most of the immunotherapeutic strategies that have been proposed during the last decade. Right after the pioneering success of Ipilimumab (anti-CTLA4) in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Zitvogel, Laurence, Kroemer, Guido
Materialtyp: Artigo
Språk:Inglês
Publicerad: Landes Bioscience 2012
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3518493/
https://ncbi.nlm.nih.gov/pubmed/23243584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.21335
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!